This could also explain the earlier onset and enhanced disease severity observed in homozygous MJD patients — they carry two disease-causing ATXN3 alleles and lack the protective function carried by wild-type ataxin-3. The gene discussed is ATXN3; the disease is Spinocerebellar ataxia type 3.